These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Studies on the T4+2H4+ cell of peripheral blood lymphocyte in systemic lupus erythematosus]. Jiang M, Sun HY, Zu LP. Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):426-8, 457. PubMed ID: 1684317 [Abstract] [Full Text] [Related]
3. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Wouters CH, Diegenant C, Ceuppens JL, Degreef H, Stevens EA. Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365 [Abstract] [Full Text] [Related]
4. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus. Cabrera CM, Urra JM, Carreño A, Zamorano J. Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231 [Abstract] [Full Text] [Related]
5. [Lymphocyte phenotypes and their correlation with clinical features in systemic lupus erythematosus (SLE)]. Bi LQ, Song Y, Sun RW. Zhonghua Nei Ke Za Zhi; 1990 Dec; 29(12):720-2, 764-5. PubMed ID: 1982646 [Abstract] [Full Text] [Related]
7. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus. Sierakowski S, Kucharz EJ. Med Interne; 1988 Dec; 26(1):67-73. PubMed ID: 3261032 [Abstract] [Full Text] [Related]
8. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus. Amel-Kashipaz MR, Huggins ML, Lanyon P, Robins A, Todd I, Powell RJ. J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124 [Abstract] [Full Text] [Related]
9. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y. Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734 [Abstract] [Full Text] [Related]
10. Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm. Kammer GM. J Clin Invest; 2005 Apr; 115(4):836-40. PubMed ID: 15841173 [Abstract] [Full Text] [Related]
11. Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides. Dar SA, Das S, Ramachandran VG, Bhattacharya SN, Mustafa MD, Banerjee BD, Verma P. J Immunotoxicol; 2012 Apr; 9(1):85-95. PubMed ID: 22214240 [Abstract] [Full Text] [Related]
16. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus. Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q. Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711 [Abstract] [Full Text] [Related]
17. A subset of CD4+ T cells expressing early activation antigen CD69 in murine lupus: possible abnormal regulatory role for cytokine imbalance. Ishikawa S, Akakura S, Abe M, Terashima K, Chijiiwa K, Nishimura H, Hirose S, Shirai T. J Immunol; 1998 Aug 01; 161(3):1267-73. PubMed ID: 9686587 [Abstract] [Full Text] [Related]
18. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus. Zhao L, Jiang Z, Jiang Y, Ma N, Wang K, Zhang Y, Feng L. Exp Biol Med (Maywood); 2013 Feb 01; 238(2):193-9. PubMed ID: 23576801 [Abstract] [Full Text] [Related]
19. Decreased number of peripheral blood CD4 + CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus. Gorla R, Airò P, Franceschini F, Stefani E, Braga S, Tincani A, Cattaneo R. J Rheumatol; 1990 Aug 01; 17(8):1048-53. PubMed ID: 1698987 [Abstract] [Full Text] [Related]